CME

CME

By ReachMDMedicine
Download on the App Store

CME episodes

  • Pathophysiology and Pharmacologic Rationale of Emerging Agents for the Treatment of PTSD
    Guest: Roger McIntyre, MD
    Guest: Joseph F. Goldberg, MD

    Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

    6 min
  • AAD Treatment Evolution: The Future of Emerging Therapies
    Guest: C. Brendan Montano, MD
    Guest: Anton P. Porsteinsson, MD

    This series of bite-sized episodes contains important information on diagnosing and treating agitation in Alzheimer’s disease (AAD). Drs. Anton Porsteinsson and Brendan Montano discuss best practices for recognizing early symptoms, diagnosing patients, and treating their AAD.

    6 min
  • Proactively Uncovering Potential Traumatic Experiences Linked to Patient Psychiatric Symptoms in Women
    Guest: Roger McIntyre, MD
    Guest: Joseph F. Goldberg, MD

    Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

    6 min
  • Conversations With Patients About PTSD, Screening, and Referral
    Guest: Joseph F. Goldberg, MD
    Guest: Roger McIntyre, MD

    Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

    6 min
  • Limitations of Current Treatments: FDA-Approved and Off-Label Approaches
    Guest: Joseph F. Goldberg, MD
    Guest: Roger McIntyre, MD

    Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

    6 min
  • Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms and Emerging Treatment Options
    Guest: Roger McIntyre, MD
    Guest: Joseph F. Goldberg, MD

    Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with the objective of providing clinicians with key action steps to take to improve outcomes for patients affected by PTSD.

    5 min
  • Mapping the Mind: The Pathophysiology That Drives AAD
    Guest: C. Brendan Montano, MD
    Guest: Anton P. Porsteinsson, MD

    This series of bite-sized episodes contains important information on diagnosing and treating agitation in Alzheimer’s disease (AAD). Drs. Anton Porsteinsson and Brendan Montano discuss best practices for recognizing early symptoms, diagnosing patients, and treating their AAD.

    5 min
  • Caregiver Screening Tools for Agitation in Alzheimer’s Disease
    Guest: C. Brendan Montano, MD
    Guest: Anton P. Porsteinsson, MD

    This series of bite-sized episodes contains important information on diagnosing and treating agitation in Alzheimer’s disease (AAD). Drs. Anton Porsteinsson and Brendan Montano discuss best practices for recognizing early symptoms, diagnosing patients, and treating their AAD.

    6 min